
Acelostat P Tab
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Voglibose 0.2 mg + Metformin (strength unknown) tablet
Type 2 diabetes mellitus (adjunct to diet and exercise) to help control post-meal (postprandial) and fasting blood glucose, especially when single therapy is inadequate
Voglibose is an alpha-glucosidase inhibitor that slows carbohydrate digestion in the intestine, reducing post-meal glucose spikes. Metformin improves insulin sensitivity and decreases glucose production by the liver, helping lower overall blood sugar.
Take orally exactly as prescribed. Typically, voglibose-containing tablets are taken with the first bite of each main meal; metformin is best taken with food to reduce stomach upset. Swallow with water; do not crush/chew unless advised. Dose is individualized based on glucose control and tolerability.
Common side effects of Voglistat M 0.2 Tab may include:

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery
STATURE LIFE SCIENCES PRIVATE - tablet - 10 S
Standard delivery

STATURE LIFE SCIENCES PRIVATE - tablet - 200 mg - 10 S
Standard delivery
For prescription use in type 2 diabetes only. Metformin may rarely cause lactic acidosis—seek urgent care for rapid breathing, severe weakness, unusual sleepiness, abdominal pain, or muscle cramps; risk increases with kidney disease, dehydration, sepsis, heavy alcohol use, and severe heart/liver disease. Avoid in severe renal impairment; kidney function should be assessed before and during treatment. Hold metformin temporarily around iodinated contrast imaging or major surgery as advised. Voglibose commonly causes gas/diarrhea; avoid in inflammatory bowel disease, intestinal obstruction, or chronic intestinal disorders. Monitor blood glucose and HbA1c; risk of hypoglycemia increases if used with insulin/sulfonylureas (treat low sugar with glucose/dextrose, not sucrose).